School of Medicine
Showing 251-300 of 905 Results
-
Jonathan Yong Lee (Jon Lee)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jon Lee, MD, MBA is a Health Policy (Health Economics) PhD candidate, Economics PhD minor candidate, and Political Science MA student. In addition, Jon Lee is a Clinical Assistant Professor of Psychiatry and Behavioral Sciences at the Depression Clinic of Stanford University where he founded the "Am I Good? Examining life through the lenses of Philosophical Skepticism, Moral Philosophy, and Existentialism" philosophical psychotherapy group.
Jon Lee's research focuses on the causes and consequences of, as well as solutions to, rising skepticism and distrust in sources of expert information (e.g., science, health). He has a special interest in exploring skepticism and persuasion at the intersection of health and politics, which includes studying phenomena such as the politicization of science and health, political polarization, filter bubbles/echo chambers, the emerging post-truth world, and information warfare. It also includes seeking heteorgeneity in the findings across particular demographics at high socioeconomic and health risk. He draws on theories and methods from his uniquely interdisciplinary set of educational, research, and professional experiences, including those from experimental and behavioral economics, political science, psychology, philosophy, and machine learning. He is currently using machine learning-based text analytics to explore how trust/distrust in sources of expert information is discussed on traditional and social media -- followed by the use of online randomized controlled survey experiments to test the causal effects of particular persuasion strategies on perceptions of trust/distrust, as well as other important behavioral outcomes of interest.
Jon Lee uses a clinical approach that consists of the use of both psychopharmacological and individual/group psychotherapeutic interventions to address depression, dissatisfaction, and unhappiness. Referred to by some as philosophical psychiatry, philosophical therapy, philosophical counseling, or philosophical psychology, Jon Lee's approach to psychotherapy/counseling begins with the building of one's worldview / lens from a first principles perspective by asking the fundamental questions posed by philosophers and scientists spanning philosophical / intellectual traditions across time, including:
existentialism / existential philosophy
philosophical empiricism
philosophical skepticism, absurdism, pessimism, nihilism
logical empiricism / logical positivism
moral / ethical philosophy, skepticism, relativism
rational skepticism / scientific skepticism
political liberalism
Questions include 'how do we know what we know?', 'what is the meaning of life?', 'what is the purpose of life?', 'does God exist?', 'what matters?', 'what is value?', 'what is good?', 'do we have moral obligations?', 'what are our moral obligations?', 'do we have rights?', 'what are rights?', 'do we have free will?', etc.
Jon Lee's approach draws heavily from the philosophical works of Epicurus, Baruch Spinoza, David Hume, Friedrich Nietzsche, Ludwig Wittgenstein, Arthur Schopenhauer, Albert Camus, Jean-Paul Sartre, John Rawles, etc. -
Jooho Lee
Graduate, Medicine, Radiology
BioJooho is a visiting PhD student researcher at Stanford University, working with Prof. Adam Wang in the Department of Radiology. His research focuses on solving inverse problems in medical imaging and computer vision, with an emphasis on X-ray computed tomography (CT) imaging. He aims to develop AI-driven solutions to improve healthcare and medicine.
-
Julie Jung Hyun Lee
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJulie Lee is a board-certified internal medicine physician and clinical informaticist at Stanford University. Dr. Lee's expertise in clinical informatics enables her to use informatics-driven approaches and clinically integrate AI models to improve patient health outcomes, alleviate physician burnout by streamlining workflows, and champion health equity at all levels. Dr. Lee focuses on clinical feasibility of AI implementation in healthcare systems and also leveraging patient data and AI models to identify/mitigate health disparities, making certain they function as instruments of equity rather than increasing gaps.
Dr. Lee has been key to several initiatives in improving operational processes within Stanford. Her efforts include: 1) advancing the governance and operations of Clinical Decision Support, 2) strategic integration of the Prescription Drug Monitoring Program into the electronic health record (EHR) to address the opioid crisis 3) human factors analysis of the usability of health information technology on physicians and patient outcomes. Additionally, she has worked on innovative solutions to improve patient-physician communications--including the creation of a dynamic EHR tool for better triage and processing by medical staff before a medical advice request reaches the doctors.
Health equity is her north star, informing Dr. Lee to dedicated engagement with historically underrepresented populations in medical research and collaborative partnerships between academia and community healthcare practitioners. Her previous role as an EpiScholar with the Los Angeles Department of Public Health involved researching the impact of language and acculturation on the Latino population's dietary habits and health behaviors, with a particular focus on diabetes. She has also worked with community health centers in east Los Angeles to bridge the translational gap between academic research and frontline healthcare workers, facilitating the transfer of cutting-edge liver disease research to those treating patients with substance abuse-related liver conditions.
Of major clinical interest is cardiovascular disease—she has published several papers including a landmark article on the impact of sex-specific risk factors for cardiovascular disease in women and transgender population. She is interested in improving precision health for Asians and NHPI. -
Sandra Soo-Jin Lee, Ph.D
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsDr. Lee is a medical anthropologist whose research focuses on the sociocultural dimensions and ethical issues of emerging technologies and their translation into clinical practice. Dr. Lee leads studies on the public understandings of research using clinical data and biological samples, concepts of race, culture and human genetic variation, and citizen science, commercialization of biotechnology and entrepreneurship.
-
Seolhyun Lee, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Lee is a nephrologist and Clinical Assistant Professor in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, and Blood Purification.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Sukmook Lee
Visiting Professor, Neurosurgery
BioProfessor Sukmook Lee, Ph.D., is a distinguished expert in the field of antibody engineering and therapeutic antibody development. He currently serves as the Director of the Antibody Research Institute and Professor in the Department of Biopharmaceutical Chemistry at Kookmin University. Additionally, he holds a Visiting Professorship in the Department of Neurosurgery at Stanford University School of Medicine. His cutting-edge research is globally recognized, particularly for its focus on immunological disorders, infectious diseases, and cancer therapies.
As the head of the Innovative Antibodies Laboratory (InnoAbs), a globally leading research group, Professor Lee spearheads pioneering efforts to develop novel therapeutic antibodies. His lab’s work has made significant strides in cancer immunotherapy, COVID-19 treatment, and the creation of diagnostic antibodies for COVID-19. The InnoAbs Lab also collaborates extensively with academic and industrial partners to drive innovation in therapeutic targeting, cancer progression, and metastasis.
Professor Lee is widely recognized in the scientific community, serving on the editorial boards of high-impact journals such as Scientific Reports, Antibodies, and Frontiers in Bioscience. He also contributes as a bio-advisory board member for leading pharmaceutical companies, including Samsung Biologics, Samsung Bioepis, ISU Abxis, and Ankook Pharmaceutical. His extensive consulting work for both international and domestic industries highlights his pivotal role in bridging academic research with practical medical applications. In addition, he serves as a steering committee member for the Korean Society for Biochemistry and Molecular Biology (KSBMB) and the Antibody Society of Korea (ASK), and is an active member of The Antibody Society and the American Association for Cancer Research (AACR) in the USA.
A visionary researcher, Professor Lee continues to push the boundaries of modern medicine, particularly through his efforts to commercialize groundbreaking antibody platforms for cancer and viral therapies, bringing new hope to patients worldwide. -
Tien-Ching Lee
Affiliate, Orthopaedic Surgery
Visiting Scholar, Orthopaedic SurgeryBioI am an orthopedic surgeon and assistant professor at Kaohsiung Medical University (KMU), serving in the Department of Orthopaedics at Kaohsiung Medical University Hospital, Taiwan. I completed my Ph.D. at KMU in 2023, focusing on orthopedic research and innovation.
My clinical expertise and research interests encompass orthopedic trauma, hand surgery, osteoporosis, and fracture repair. My work has been recognized with several prestigious awards, including the 2018 Merit Paper Award from the Taiwanese Osteoporosis Association and the 2019 AOTAP Scientific Congress Merit Paper Award.
As part of a dynamic research team, I have contributed to significant medical device innovations. Our developments include a novel targeting device for screw positioning and an advanced surgical tool for carpal tunnel release. These innovations have secured patents across multiple jurisdictions, including the United States, Taiwan, China, European nations, and Singapore. Our achievements have been honored with the Taiwan National Innovation Award for four consecutive years (2019, 2020, 2022, and 2024).
Currently, I am a visiting scholar in Dr. Yang's laboratory at Stanford University, where I am expanding my expertise in innovation, research, and development while fostering international collaborations. This aligns with my commitment to advancing orthopedic care through global knowledge exchange and professional networking.
